{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:21:24Z","timestamp":1790292084820,"version":"4.1.0"},"reference-count":93,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T00:00:00Z","timestamp":1548201600000},"content-version":"vor","delay-in-days":387,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","onlinejacc.org","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.jacc.2017.11.019","type":"journal-article","created":{"date-parts":[[2018,1,16]],"date-time":"2018-01-16T11:08:31Z","timestamp":1516100911000},"page":"339-351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":325,"title":["Implications of Underlying Mechanisms for\u00a0the Recognition and Management of Diabetic Cardiomyopathy"],"prefix":"10.1016","volume":"71","author":[{"given":"Thomas H.","family":"Marwick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Ritchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan E.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2017.11.019_bib1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4239\/wjd.v4.i5.177","article-title":"Diabetic cardiomyopathy: pathophysiology, diagnostic evaluation and management","volume":"4","author":"Pappachan","year":"2013","journal-title":"World J Diabetes"},{"key":"10.1016\/j.jacc.2017.11.019_bib2","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","article-title":"New type of cardiomyopathy associated with diabetic glomerulosclerosis","volume":"30","author":"Rubler","year":"1972","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2017.11.019_bib3","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1242\/dmm.001941","article-title":"Rodent models of diabetic cardiomyopathy","volume":"2","author":"Bugger","year":"2009","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.jacc.2017.11.019_bib4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0002-9149(74)90089-7","article-title":"Role of diabetes in congestive heart failure: the Framingham study","volume":"34","author":"Kannel","year":"1974","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2017.11.019_bib5","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.2337\/diacare.27.8.1879","article-title":"The incidence of congestive heart failure in type 2 diabetes: an update","volume":"27","author":"Nichols","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2017.11.019_bib6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S2213-8587(14)70219-0","article-title":"Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1.9 million people","volume":"3","author":"Shah","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacc.2017.11.019_bib7","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00592-013-0455-0","article-title":"Myocardial dysfunction and chronic heart failure in patients with long-lasting type 1 diabetes: a 7-year prospective cohort study","volume":"50","author":"Konduracka","year":"2013","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.jacc.2017.11.019_bib8","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jcmg.2014.12.020","article-title":"Global longitudinal strain is not impaired in type 1 diabetes patients without albuminuria: the Thousand & 1 study","volume":"8","author":"Jensen","year":"2015","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2017.11.019_bib9","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1042\/CS20070261","article-title":"Prevalence and predictors of cardiac hypertrophy and dysfunction in patients with type 2 diabetes","volume":"114","author":"Srivastava","year":"2008","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jacc.2017.11.019_bib10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jdiacomp.2013.09.013","article-title":"Prevalence, predictors and evolution of echocardiographically defined cardiac abnormalities in adults with type 1 diabetes: an observational cohort study","volume":"28","author":"Wai","year":"2014","journal-title":"J\u00a0Diabetes Complications"},{"key":"10.1016\/j.jacc.2017.11.019_bib11","doi-asserted-by":"crossref","first-page":"612","DOI":"10.2337\/diacare.28.3.612","article-title":"The association between glucose abnormalities and heart failure in the population-based Reykjavik study","volume":"28","author":"Thrainsdottir","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2017.11.019_bib12","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.jacc.2007.12.048","article-title":"Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study","volume":"51","author":"Bahrami","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.11.019_bib13","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ncpcardio0943","article-title":"Obesity cardiomyopathy: pathogenesis and pathophysiology","volume":"4","author":"Wong","year":"2007","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10.1016\/j.jacc.2017.11.019_bib14","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1253\/circj.CJ-11-0754","article-title":"Prevalence and prognostic implications of pre-diabetic state in patients with heart failure","volume":"75","author":"Matsue","year":"2011","journal-title":"Circ J"},{"key":"10.1016\/j.jacc.2017.11.019_bib15","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jacc.2003.11.024","article-title":"Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure","volume":"43","author":"Gustafsson","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.11.019_bib16","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/eurheartj\/ehn153","article-title":"Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme","volume":"29","author":"MacDonald","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2017.11.019_bib17","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s00125-014-3171-6","article-title":"Molecular mechanisms of diabetic cardiomyopathy","volume":"57","author":"Bugger","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.jacc.2017.11.019_bib18","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.pharmthera.2014.01.003","article-title":"Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways","volume":"142","author":"Huynh","year":"2014","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jacc.2017.11.019_bib19","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1042\/CS20160491","article-title":"Are targeted therapies for diabetic cardiomyopathy on the horizon?","volume":"131","author":"Tate","year":"2017","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jacc.2017.11.019_bib20","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1177\/1479164117710390","article-title":"Insulin replacement limits progression of diabetic cardiomyopathy in the low-dose streptozotocin-induced diabetic rat","volume":"14","author":"Tate","year":"2017","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.jacc.2017.11.019_bib21","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1161\/01.CIR.103.22.2668","article-title":"Glycemic control and heart failure among adult patients with diabetes","volume":"103","author":"Iribarren","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.11.019_bib22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.phrs.2016.12.016","article-title":"Insights into the role of maladaptive hexosamine biosynthesis and O-GlcNAcylation in development of diabetic cardiac complications","volume":"116","author":"Qin","year":"2017","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jacc.2017.11.019_bib23","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.cardiores.2004.05.001","article-title":"Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes","volume":"63","author":"Basta","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2017.11.019_bib24","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.tibs.2010.04.005","article-title":"O-GIcNAc signaling: a metabolic link between diabetes and cancer?","volume":"35","author":"Slawson","year":"2010","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.jacc.2017.11.019_bib25","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1021\/acs.jproteome.6b00250","article-title":"Comparative proteomics reveals dysregulated mitochondrial O-GlcNAcylation in diabetic hearts","volume":"15","author":"Ma","year":"2016","journal-title":"J\u00a0Proteome Res"},{"key":"10.1016\/j.jacc.2017.11.019_bib26","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1007\/s00125-012-2495-3","article-title":"Coenzyme Q(10) attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db\/db mouse model of type 2 diabetes","volume":"55","author":"Huynh","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.jacc.2017.11.019_bib27","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/ncpcardio1347","article-title":"Interplay between impaired calcium regulation and insulin signaling abnormalities in diabetic cardiomyopathy","volume":"5","author":"Lebeche","year":"2008","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10.1016\/j.jacc.2017.11.019_bib28","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1007\/s00125-012-2720-0","article-title":"Enhanced phosphoinositide 3-kinase (p110a) activity prevents diabetes\u2013induced cardiomyopathy and superoxide generation in a mouse model of diabetes","volume":"55","author":"Ritchie","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.jacc.2017.11.019_bib29","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.cmet.2011.07.015","article-title":"Insulin resistance, hyperglycemia, and atherosclerosis","volume":"14","author":"Bornfeldt","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.jacc.2017.11.019_bib30","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1475-2840-8-58","article-title":"Elevated plasma levels of TNF-alpha and interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders","volume":"8","author":"Dinh","year":"2009","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jacc.2017.11.019_bib31","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nri2925","article-title":"Type 2 diabetes as an inflammatory disease","volume":"11","author":"Donath","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jacc.2017.11.019_bib32","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.freeradbiomed.2013.02.021","article-title":"Targeting the upregulation of reactive oxygen species subsequent to hyperglycemia prevents type 1 diabetic cardiomyopathy in mice","volume":"60","author":"Huynh","year":"2013","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jacc.2017.11.019_bib33","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1161\/01.CIR.100.8.813","article-title":"Effects of autonomic neuropathy on coronary blood flow in patients with diabetes mellitus","volume":"100","author":"Di Carli","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.11.019_bib34","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2174\/157339910790909396","article-title":"Cardiovascular and renal complications of type 2 diabetes in obesity: role of sympathetic nerve activity and insulin resistance","volume":"6","author":"Masuo","year":"2010","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/j.jacc.2017.11.019_bib35","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2174\/1573403X12666160606120254","article-title":"Type 2 diabetes and heart failure: challenges and solutions","volume":"12","author":"Thomas","year":"2016","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/j.jacc.2017.11.019_bib36","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1152\/physrev.00015.2009","article-title":"Myocardial fatty acid metabolism in health and disease","volume":"90","author":"Lopaschuk","year":"2010","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jacc.2017.11.019_bib37","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/cvr\/cvq239","article-title":"Mitochondria in the diabetic heart","volume":"88","author":"Bugger","year":"2010","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2017.11.019_bib38","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1172\/JCI60329","article-title":"Metabolic stress-induced activation of FoxO1 triggers diabetic cardiomyopathy in mice","volume":"122","author":"Battiprolu","year":"2012","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacc.2017.11.019_bib39","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1042\/CS20170063","article-title":"Phosphoinositide 3-kinase (p110 alpha) gene delivery limits diabetes-induced cardiac NADPH oxidase and cardiomyopathy in a mouse model with established diastolic dysfunction","volume":"131","author":"Prakoso","year":"2017","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jacc.2017.11.019_bib40","doi-asserted-by":"crossref","first-page":"E1119","DOI":"10.1152\/ajpendo.00029.2008","article-title":"Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level","volume":"294","author":"Feng","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jacc.2017.11.019_bib41","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1194\/jlr.R066514","article-title":"Lipid signaling and lipotoxicity in metaflammation: indications for metabolic disease pathogenesis and treatment","volume":"57","author":"Ertunc","year":"2016","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jacc.2017.11.019_bib42","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.jacc.2008.07.062","article-title":"Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus","volume":"52","author":"Rijzewijk","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.11.019_bib43","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.yjmcc.2011.08.009","article-title":"Protein O-linked beta-N-acetylglucosamine: a novel effector of cardiomyocyte metabolism and function","volume":"52","author":"Darley-Usmar","year":"2012","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacc.2017.11.019_bib44","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1161\/CIRCULATIONAHA.113.008476","article-title":"Myocardial contractile dysfunction is associated with impaired mitochondrial function and dynamics in type 2 diabetic but not in obese patients","volume":"130","author":"Montaigne","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.11.019_bib45","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jacc.2010.09.040","article-title":"Obesity induces signs of premature cardiac aging in younger patients the role of mitochondria","volume":"57","author":"Niemann","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.11.019_bib46","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/clc.4960230407","article-title":"Plasma big-endothelin levels, cardiac autonomic neuropathy, and cardiac functions in patients with insulin-dependent diabetes mellitus","volume":"23","author":"Erbas","year":"2000","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2017.11.019_bib47","doi-asserted-by":"crossref","first-page":"R510","DOI":"10.1152\/ajpregu.00512.2011","article-title":"Intracardiac intracellular angiotensin system in diabetes","volume":"302","author":"Kumar","year":"2012","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.jacc.2017.11.019_bib48","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/S0735-1097(03)00166-9","article-title":"Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes","volume":"41","author":"Di Carli","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.11.019_bib49","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1475-2840-10-80","article-title":"Impact of type 2 diabetes and the metabolic syndrome on myocardial structure and microvasculature of men with coronary artery disease","volume":"10","author":"Campbell","year":"2011","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jacc.2017.11.019_bib50","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/1440-1681.12070","article-title":"Functional relevance of genetic variations of endothelial nitric oxide synthase and vascular endothelial growth factor in diabetic coronary microvessel dysfunction","volume":"40","author":"Joshi","year":"2013","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.jacc.2017.11.019_bib51","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1161\/CIRCULATIONAHA.114.009625","article-title":"Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction","volume":"131","author":"Mohammed","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.11.019_bib52","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1042\/CS20030153","article-title":"Relationship between longitudinal and radial contractility in subclinical diabetic heart disease","volume":"106","author":"Fang","year":"2004","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jacc.2017.11.019_bib53","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.echo.2014.01.001","article-title":"Longitudinal myocardial strain alteration is associated with left ventricular remodeling in asymptomatic patients with type 2 diabetes mellitus","volume":"27","author":"Ernande","year":"2014","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.jacc.2017.11.019_bib54","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.amjcard.2003.12.026","article-title":"Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus","volume":"93","author":"Boyer","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2017.11.019_bib55","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jacc.2009.12.003","article-title":"The development of heart failure in patients with diabetes mellitus and pre-clinical diastolic dysfunction a population-based study","volume":"55","author":"From","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.11.019_bib56","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1136\/heartjnl-2014-307391","article-title":"Subclinical LV dysfunction and 10-year outcomes in type 2 diabetes mellitus","volume":"101","author":"Holland","year":"2015","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2017.11.019_bib57","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/jama.1994.03510350050036","article-title":"Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study","volume":"271","author":"Benjamin","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2017.11.019_bib58","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/ehjci\/jes084","article-title":"Changes in left atrial volume in diabetes mellitus: more than diastolic dysfunction?","volume":"13","author":"Kadappu","year":"2012","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2017.11.019_bib59","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/CIRCULATIONAHA.107.728550","article-title":"Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension","volume":"117","author":"van Heerebeek","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.11.019_bib60","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.amjcard.2013.04.028","article-title":"Comparison of three-dimensional echocardiographic findings to those of magnetic resonance imaging for determination of left ventricular mass in patients with ischemic and non-ischemic cardiomyopathy","volume":"112","author":"Kusunose","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2017.11.019_bib61","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2337\/db15-0627","article-title":"Relationship between left ventricular structural and metabolic remodeling in type 2 diabetes","volume":"65","author":"Levelt","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.jacc.2017.11.019_bib62","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1161\/CIRCIMAGING.111.963587","article-title":"Association of imaging markers of myocardial fibrosis with metabolic and functional disturbances in early diabetic cardiomyopathy","volume":"4","author":"Jellis","year":"2011","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2017.11.019_bib63","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/eht193","article-title":"Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission","volume":"35","author":"Wong","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2017.11.019_bib64","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1172\/JCI40096","article-title":"Excessive cardiac insulin signaling exacerbates systolic dysfunction induced by pressure overload in rodents","volume":"120","author":"Shimizu","year":"2010","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacc.2017.11.019_bib65","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.jacc.2017.07.792","article-title":"Clinical implications of echocardiographic phenotypes of patients with diabetes mellitus","volume":"70","author":"Ernande","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.11.019_bib66","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.ahj.2006.05.007","article-title":"Population-based detection of systolic and diastolic dysfunction with amino-terminal pro-B-type natriuretic peptide","volume":"152","author":"Abhayaratna","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2017.11.019_bib67","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/j.bbadis.2017.03.013","article-title":"Role of microRNA in diabetic cardiomyopathy: from mechanism to intervention","volume":"1863","author":"Guo","year":"2017","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jacc.2017.11.019_bib68","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2337\/db08-0994","article-title":"Site-specific GlcNAcylation of human erythrocyte proteins potential biomarker(s) for diabetes","volume":"58","author":"Wang","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.jacc.2017.11.019_bib69","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1161\/CIRCULATIONAHA.105.584524","article-title":"Stress testing in patients with diabetes mellitus: diagnostic and prognostic value","volume":"113","author":"Albers","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.11.019_bib70","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2471\/BLT.07.050112","article-title":"Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years","volume":"86","author":"Andermann","year":"2008","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.jacc.2017.11.019_bib71","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.2009.476","article-title":"Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial","volume":"301","author":"Young","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2017.11.019_bib72","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jacc.2017.07.001","article-title":"Primary Prevention of Cardiovascular Disease in Diabetes Mellitus","volume":"70","author":"Newman","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.11.019_bib73","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.amjcard.2017.06.048","article-title":"Prognostic usefulness of cardiac stress test modalities in patients with type 2 diabetes mellitus who underwent myocardial perfusion scintigraphy (from the Basel Asymptomatic High-Risk Diabetics' Outcome Trial)","volume":"120","author":"Caobelli","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2017.11.019_bib74","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.11.019_bib75","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/CIRCHEARTFAILURE.111.964841","article-title":"Prediction of incident heart failure in general practice: the Atherosclerosis Risk in Communities (ARIC) Study","volume":"5","author":"Agarwal","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2017.11.019_bib76","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/ejhf.643","article-title":"Echocardiographic screening for non-ischaemic stage B heart failure in the community","volume":"18","author":"Yang","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2017.11.019_bib77","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1055\/s-0029-1216374","article-title":"Heat shock protein 27 modification is increased in the human diabetic failing heart","volume":"41","author":"Gawlowski","year":"2009","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.jacc.2017.11.019_bib78","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s11892-016-0797-4","article-title":"Sitting less and moving more: improved glycaemic control for type 2 diabetes prevention and management","volume":"16","author":"Dempsey","year":"2016","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.jacc.2017.11.019_bib79","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1212914","article-title":"Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes","volume":"369","author":"Look","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.11.019_bib80","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2337\/dc15-1990","article-title":"Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes: the DCCT\/EDIC study 30-year follow-up","volume":"39","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2017.11.019_bib81","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1161\/CIRCHEARTFAILURE.113.000920","article-title":"Both high and low HbA1c predict incident heart failure in type 2 diabetes mellitus","volume":"8","author":"Parry","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2017.11.019_bib82","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1161\/CIRCULATIONAHA.108.832915","article-title":"Increased glucose uptake and oxidation in mouse hearts prevent high fatty acid oxidation but cause cardiac dysfunction in diet-induced obesity","volume":"119","author":"Yan","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.11.019_bib83","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1161\/CIRCULATIONAHA.115.017355","article-title":"The Failing heart relies on ketone bodies as a fuel","volume":"133","author":"Aubert","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.11.019_bib84","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/S0140-6736(14)61402-1","article-title":"Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy","volume":"385","author":"Gilbert","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2017.11.019_bib85","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.11.019_bib86","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/CIRCULATIONAHA.117.029190","volume":"136","author":"Kosiborod","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.11.019_bib87","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","article-title":"Oxidative stress and diabetic complications","volume":"107","author":"Giacco","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2017.11.019_bib88","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1161\/HYPERTENSIONAHA.109.145136","article-title":"Nebivolol improves diastolic dysfunction and myocardial remodeling through reductions in oxidative stress in the Zucker obese rat","volume":"55","author":"Zhou","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2017.11.019_bib89","first-page":"641","article-title":"The effect of coenzyme Q(10) on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial","volume":"2","author":"Mortensen","year":"2014","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2017.11.019_bib90","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1749-6632.2010.05627.x","article-title":"Animal and human studies with the mitochondria-targeted antioxidant MitoQ","volume":"1201","author":"Smith","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jacc.2017.11.019_bib91","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00125-017-4215-5","article-title":"Combined NOX1\/4 inhibition with GKT137831 in mice provides dose-dependent reno- and atheroprotection even in established micro- and macrovascular disease","volume":"60","author":"Gray","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.jacc.2017.11.019_bib92","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1161\/CIRCULATIONAHA.107.760405","article-title":"Parasympathetic nervous system and heart failure: pathophysiology and potential implications for therapy","volume":"118","author":"Olshansky","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.11.019_bib93","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.2337\/db13-0683","article-title":"Diabetes and the heart: is there objective evidence of a human diabetic cardiomyopathy?","volume":"62","author":"Litwin","year":"2013","journal-title":"Diabetes"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109717416330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109717416330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T13:36:44Z","timestamp":1660311404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109717416330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":93,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0735109717416330"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2017.11.019","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implications of Underlying Mechanisms for\u00a0the Recognition and Management of Diabetic Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2017.11.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}